Doctors have long suspected it; now patients are admitting it. A new survey from University of Utah Health finds that 28 percent of Americans — more than one in four — have exaggerated or made up symptoms in order to obtain antibiotics from their doctor. The findings cast the familiar problem of antibiotic overuse in a new light: it is not only about prescribing habits, but about what patients say in the consultation room.
Why Patients Bend the Truth
The motivations the survey uncovered are more sympathetic than cynical. Common reasons included feeling genuinely very unwell and needing to get back to work. Antibiotics carry a powerful reputation as the medicine that fixes things, and for people facing lost wages or caring responsibilities, the pressure to recover quickly can outweigh abstract warnings about resistance.
The misunderstanding at the root is durable: antibiotics treat bacterial infections, not the viruses behind most colds, flu and sore throats. Prescribing them for viral illness does patients no good, exposes them to side effects, and accelerates the resistance that makes the drugs fail when they are truly needed. The study features in current public health research releases alongside other work on prescribing behaviour.
The Antibiotics Resistance Stakes
Antimicrobial resistance is among the World Health Organization’s top global health threats, rendering once-routine infections harder and sometimes impossible to treat. Every unnecessary course of antibiotics applies selection pressure, rewarding the bacteria that survive it. Clinicians describe the resulting dilemma vividly: the patient in front of them wants help today, while the cost is paid by future patients they will never meet.
Public health communication has struggled to close this gap, as our coverage of the measles update and how vaccination prevents spread illustrates in a different arena — clear scientific consensus does not automatically produce public behaviour to match.
What Could Actually Help
Researchers and stewardship programmes point to several levers: delayed prescriptions that patients use only if symptoms persist, rapid tests that distinguish viral from bacterial infections, and consultation scripts that validate how ill a patient feels while explaining why an antibiotic will not help. Addressing the work-pressure motive matters too; people who cannot afford sick days will keep asking for the fastest fix they believe exists.
Honesty in the survey is itself a useful signal. Patients who admit exaggerating are not villains of the story — they are describing a system in which the quickest route to feeling better appears to run through a prescription pad.
The survey’s real message is not that patients lie, but that they are desperate enough to. Tackling antibiotic resistance will require treating that desperation — with better tests, better sick-pay realities and better conversations — as seriously as the prescribing guidelines themselves.
